Paul Knight analyst KEYBANK

Currently out of the existing stock ratings of Paul Knight, 121 are a BUY (94.53%), 7 are a HOLD (5.47%).

Paul Knight

Work Performance Price Targets & Ratings Chart

Analyst Paul Knight, currently employed at KEYBANK, carries an average stock price target met ratio of 51.8% that have a potential upside of 35.13% achieved within 146 days.

Paul Knight’s has documented 245 price targets and ratings displayed on 22 stocks. The coverage is on Healthcare, Basic Materials, Technology, Industrials sectors.

Most recent stock forecast was given on CSTL, Castle Biosciences at 05-Nov-2024.

Wall Street Analyst Paul Knight

Analyst best performing recommendations are on CYRX (CRYOPORT).
The best stock recommendation documented was for CYRX (CRYOPORT) at 1/19/2021. The price target of $75 was fulfilled within 3 days with a profit of $10.82 (16.86%) receiving and performance score of 56.2.

Average potential price target upside

A Agilent Technologies AVTR Avantor BRKS Brooks Automation CDMO Avid Bioservices CYRX Cryoport DNAY Codex DNA HBIO Harvard Bioscience TMO Thermo Fisher Scientific VCYT Veracyte BLFS BioLife Solutions CSTL Castle Biosciences CTLT Catalent DHR Danaher MRVI Maravai Lifesciences Holdings  RGEN Repligen STVN Stevanato Group SpA TECH Bio-Techne Corp OCX OncoCyte Corp WST West Pharmaceutical Services XGN Exagen AZTA Azenta PKI PerkinElmer

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$145

$18.81 (14.91%)

$135

1 months 6 days ago
(15-Oct-2024)

5/9 (55.56%)

$0.42 (0.29%)

99

$145

$18.81 (14.91%)

$135

1 months 20 days ago
(01-Oct-2024)

4/4 (100%)

$-1.56 (-1.06%)

17

Hold

$147

$20.81 (16.49%)

$140

2 months 30 days ago
(22-Aug-2024)

6/6 (100%)

$6.78 (4.84%)

92

Buy

$200

4 months 25 days ago
(27-Jun-2024)

8/9 (88.89%)

$28.88 (16.88%)

196

Buy

$135

$8.81 (6.98%)

$146

5 months 18 days ago
(03-Jun-2024)

13/15 (86.67%)

$3.6 (2.74%)

403

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Paul Knight is most bullish on?

Potential upside of $79.5 has been obtained for DHR (DANAHER)

Which stock is Paul Knight is most reserved on?

Potential downside of $7.9 has been obtained for CSTL (CASTLE BIOSCIENCES)

What Year was the first public recommendation made by Paul Knight?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?